Z
Zachary S. Wallace
Researcher at Harvard University
Publications - 191
Citations - 9158
Zachary S. Wallace is an academic researcher from Harvard University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 31, co-authored 124 publications receiving 5735 citations. Previous affiliations of Zachary S. Wallace include Brigham and Women's Hospital & Boston Children's Hospital.
Papers
More filters
Journal ArticleDOI
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Milena A. Gianfrancesco,Kimme L. Hyrich,Sarah Al-Adely,Loreto Carmona,Maria I. Danila,Maria I. Danila,Laure Gossec,Zara Izadi,Lindsay Jacobsohn,Patricia P. Katz,Saskia Lawson-Tovey,Elsa F Mateus,Stephanie Rush,Gabriela Schmajuk,Julia F. Simard,Anja Strangfeld,Laura Trupin,Katherine D Wysham,Suleman Bhana,Wendy Costello,Rebecca Grainger,Jonathan S. Hausmann,Jonathan S. Hausmann,Jean W. Liew,Emily Sirotich,Paul Sufka,Zachary S. Wallace,Jinoos Yazdany,Pedro Machado,Philip Robinson,Philip Robinson +30 more
TL;DR: It is found that glucocorticoid exposure of ≥10 mg/day is associated with a higher odds of hospitalisation and anti-TNF with a decreased odds ofospitalisation in patients with rheumatic disease.
Journal ArticleDOI
International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease
Arezou Khosroshahi,Zachary S. Wallace,J. L. Crowe,Takashi Akamizu,Atsushi Azumi,M. N. Carruthers,Suresh T. Chari,Emanuel Della-Torre,Luca Frulloni,Hiroshi Goto,Phil A. Hart,Terumi Kamisawa,Shigeyuki Kawa,Mitsuhiro Kawano,Myung-Hwan Kim,Yuzo Kodama,Kensuke Kubota,Markus M. Lerch,Matthias Löhr,Yasufumi Masaki,Shoko Matsui,Tsuneyo Mimori,Seiji Nakamura,Takahiro Nakazawa,Hirotaka Ohara,Kazuichi Okazaki,Jay H. Ryu,Takako Saeki,Nicolas Schleinitz,Akira Shimatsu,Toru Shimosegawa,Hiroki Takahashi,Masayuki Takahira,Atsushi Tanaka,Mark Topazian,Hisanori Umehara,George J. Webster,Thomas E. Witzig,Motohisa Yamamoto,W. Zhang,Tsutomu Chiba,John H. Stone +41 more
TL;DR: A. H. Wallace, J. L. Carruthers, S. L€ ohr, Y. Khosroshahi, Z. Chari, E. Della-Torre, L. Frulloni, H.
Journal ArticleDOI
Rituximab for IgG4-related disease: a prospective, open-label trial
Mollie N. Carruthers,Mark Topazian,Arezou Khosroshahi,Thomas E. Witzig,Zachary S. Wallace,Philip A. Hart,Vikram Deshpande,Thomas C. Smyrk,Suresh T. Chari,John H. Stone +9 more
TL;DR: Rituximab appears to be an effective treatment for IgG4-RD, even without concomitant GC therapy.
Journal ArticleDOI
IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients.
Zachary S. Wallace,Vikram Deshpande,Hamid Mattoo,Vinay Mahajan,Maria Kulikova,Shiv Pillai,John H. Stone +6 more
TL;DR: In this article, the authors report detailed clinical and laboratory findings in a larger group of patients with IgG4-related disease whose diagnosis was established by strict clinicopathologic correlation.
Journal ArticleDOI
Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry.
Anja Strangfeld,Martin Schäfer,Milena A. Gianfrancesco,Saskia Lawson-Tovey,Jean W. Liew,Lotta Ljung,Elsa F Mateus,Christophe Richez,Maria José Santos,Gabriela Schmajuk,Carlo Alberto Scirè,Emily Sirotich,Jeffrey A. Sparks,Paul Sufka,Thierry Thomas,Laura Trupin,Zachary S. Wallace,Sarah Al-Adely,Javier Bachiller-Corral,Suleman Bhana,Patrice Cacoub,Loreto Carmona,Ruth Costello,Wendy Costello,Laure Gossec,Rebecca Grainger,Eric Hachulla,Rebecca Hasseli,Jonathan S. Hausmann,Kimme L. Hyrich,Zara Izadi,Lindsay Jacobsohn,Patricia P. Katz,Lianne Kearsley-Fleet,Philip Robinson,Philip Robinson,Jinoos Yazdany,Pedro Machado +37 more
TL;DR: In this paper, the authors determined factors associated with COVID-19-related death in people with rheumatic diseases, including age, sex, smoking status, comorbidities, diagnosis, disease activity and medications.